Alvotech (ALVO)
NASDAQ: ALVO · IEX Real-Time Price · USD
14.15
+0.50 (3.66%)
At close: Apr 26, 2024, 4:00 PM
14.23
+0.08 (0.57%)
After-hours: Apr 26, 2024, 5:56 PM EDT
Alvotech Employees
Alvotech had 1,026 employees on December 31, 2023. The number of employees increased by 79 or 8.34% compared to the previous year.
Employees
1,026
Change (1Y)
79
Growth (1Y)
8.34%
Revenue / Employee
$91,016
Profits / Employee
-$537,750
Market Cap
3.78B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,026 | 79 | 8.34% |
Dec 31, 2022 | 947 | 142 | 17.64% |
Mar 4, 2022 | 805 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
Envista Holdings | 12,800 |
Integer Holdings | 10,500 |
RadNet | 7,872 |
Alkermes | 2,100 |
iRhythm Technologies | 2,000 |
Ultragenyx Pharmaceutical | 1,276 |
Insmed | 912 |
ALVO News
- 3 days ago - Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab) - GlobeNewsWire
- 8 days ago - Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab) - GlobeNewsWire
- 10 days ago - Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab) - Business Wire
- 23 days ago - Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024 - GlobeNewsWire
- 5 weeks ago - Alvotech Announces Increase in Number of Own Shares - GlobeNewsWire
- 5 weeks ago - Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update - GlobeNewsWire
- 7 weeks ago - Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET - GlobeNewsWire
- 2 months ago - Alvotech Appoints Interim Chief Quality Officer - GlobeNewsWire